Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis

2017 ◽  
Vol 376 ◽  
pp. 242-254 ◽  
Author(s):  
Eva Bagyinszky ◽  
Vo Van Giau ◽  
Kyuhwan Shim ◽  
Kyoungho Suk ◽  
Seong Soo A. An ◽  
...  
2011 ◽  
Vol 25 (4) ◽  
pp. 719-726 ◽  
Author(s):  
Mauro Silvestrini ◽  
Giovanna Viticchi ◽  
Lorenzo Falsetti ◽  
Clotilde Balucani ◽  
Fabrizio Vernieri ◽  
...  

2006 ◽  
Vol 8 (1) ◽  
pp. 65-72 ◽  
Author(s):  
W.S.T. Griffin ◽  
J.G. Sheng ◽  
M.C. Royston ◽  
S.M. Gentleman ◽  
J.E. McKenzie ◽  
...  

2020 ◽  
Vol 45 (7) ◽  
pp. 1481-1491 ◽  
Author(s):  
Thuy Trang Nguyen ◽  
Qui Thanh Hoai Ta ◽  
Thi Thuy Dung Nguyen ◽  
Thi Thuy Le ◽  
Van Giau Vo

Biomolecules ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. 543
Author(s):  
Julie Gregory ◽  
Yasaswi V. Vengalasetti ◽  
Dale E. Bredesen ◽  
Rammohan V. Rao

Background—Alzheimer’s disease (AD) is a multifactorial, progressive, neurodegenerative disease that is characterized by memory loss, personality changes, and a decline in cognitive function. While the exact cause of AD is still unclear, recent studies point to lifestyle, diet, environmental, and genetic factors as contributors to disease progression. The pharmaceutical approaches developed to date do not alter disease progression. More than two hundred promising drug candidates have failed clinical trials in the past decade, suggesting that the disease and its causes may be highly complex. Medicinal plants and herbal remedies are now gaining more interest as complementary and alternative interventions and are a valuable source for developing drug candidates for AD. Indeed, several scientific studies have described the use of various medicinal plants and their principal phytochemicals for the treatment of AD. This article reviews a subset of herbs for their anti-inflammatory, antioxidant, and cognitive-enhancing effects. Methods—This article systematically reviews recent studies that have investigated the role of neuroprotective herbs and their bioactive compounds for dementia associated with Alzheimer’s disease and pre-Alzheimer’s disease. PubMed Central, Scopus, and Google Scholar databases of articles were collected, and abstracts were reviewed for relevance to the subject matter. Conclusions—Medicinal plants have great potential as part of an overall program in the prevention and treatment of cognitive decline associated with AD. It is hoped that these medicinal plants can be used in drug discovery programs for identifying safe and efficacious small molecules for AD.


2011 ◽  
Vol 24 (1) ◽  
pp. 35-45 ◽  
Author(s):  
Katie Palmer ◽  
Federica Lupo ◽  
Roberta Perri ◽  
Giovanna Salamone ◽  
Lucia Fadda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document